Why Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer’s Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue

Docosahexaenoic acid (DHA), an omega-3 fatty acid rich in seafood, is linked to Alzheimer’s Disease via strong epidemiological and pre-clinical evidence, yet fish oil or other DHA supplementation has not consistently shown benefit to the prevention or treatment of Alzheimer’s Disease. Furthermore, a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rory J. Heath, Thomas R. Wood
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
DHA
Acceso en línea:https://doaj.org/article/dbaff1d17ede42969ff211e31bf69bc9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:dbaff1d17ede42969ff211e31bf69bc9
record_format dspace
spelling oai:doaj.org-article:dbaff1d17ede42969ff211e31bf69bc92021-11-11T17:15:45ZWhy Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer’s Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue10.3390/ijms2221118261422-00671661-6596https://doaj.org/article/dbaff1d17ede42969ff211e31bf69bc92021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11826https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Docosahexaenoic acid (DHA), an omega-3 fatty acid rich in seafood, is linked to Alzheimer’s Disease via strong epidemiological and pre-clinical evidence, yet fish oil or other DHA supplementation has not consistently shown benefit to the prevention or treatment of Alzheimer’s Disease. Furthermore, autopsy studies of Alzheimer’s Disease brain show variable DHA status, demonstrating that the relationship between DHA and neurodegeneration is complex and not fully understood. Recently, it has been suggested that the forms of DHA in the diet and plasma have specific metabolic fates that may affect brain uptake; however, the effect of DHA form on brain uptake is less pronounced in studies of longer duration. One major confounder of studies relating dietary DHA and Alzheimer’s Disease may be that adipose tissue acts as a long-term depot of DHA for the brain, but this is poorly understood in the context of neurodegeneration. Future work is required to develop biomarkers of brain DHA and better understand DHA-based therapies in the setting of altered brain DHA uptake to help determine whether brain DHA should remain an important target in the prevention of Alzheimer’s Disease.Rory J. HeathThomas R. WoodMDPI AGarticleDHAomega-3Alzheimer’sdementianeurodegenerationBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11826, p 11826 (2021)
institution DOAJ
collection DOAJ
language EN
topic DHA
omega-3
Alzheimer’s
dementia
neurodegeneration
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle DHA
omega-3
Alzheimer’s
dementia
neurodegeneration
Biology (General)
QH301-705.5
Chemistry
QD1-999
Rory J. Heath
Thomas R. Wood
Why Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer’s Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue
description Docosahexaenoic acid (DHA), an omega-3 fatty acid rich in seafood, is linked to Alzheimer’s Disease via strong epidemiological and pre-clinical evidence, yet fish oil or other DHA supplementation has not consistently shown benefit to the prevention or treatment of Alzheimer’s Disease. Furthermore, autopsy studies of Alzheimer’s Disease brain show variable DHA status, demonstrating that the relationship between DHA and neurodegeneration is complex and not fully understood. Recently, it has been suggested that the forms of DHA in the diet and plasma have specific metabolic fates that may affect brain uptake; however, the effect of DHA form on brain uptake is less pronounced in studies of longer duration. One major confounder of studies relating dietary DHA and Alzheimer’s Disease may be that adipose tissue acts as a long-term depot of DHA for the brain, but this is poorly understood in the context of neurodegeneration. Future work is required to develop biomarkers of brain DHA and better understand DHA-based therapies in the setting of altered brain DHA uptake to help determine whether brain DHA should remain an important target in the prevention of Alzheimer’s Disease.
format article
author Rory J. Heath
Thomas R. Wood
author_facet Rory J. Heath
Thomas R. Wood
author_sort Rory J. Heath
title Why Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer’s Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue
title_short Why Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer’s Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue
title_full Why Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer’s Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue
title_fullStr Why Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer’s Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue
title_full_unstemmed Why Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer’s Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue
title_sort why have the benefits of dha not been borne out in the treatment and prevention of alzheimer’s disease? a narrative review focused on dha metabolism and adipose tissue
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/dbaff1d17ede42969ff211e31bf69bc9
work_keys_str_mv AT roryjheath whyhavethebenefitsofdhanotbeenborneoutinthetreatmentandpreventionofalzheimersdiseaseanarrativereviewfocusedondhametabolismandadiposetissue
AT thomasrwood whyhavethebenefitsofdhanotbeenborneoutinthetreatmentandpreventionofalzheimersdiseaseanarrativereviewfocusedondhametabolismandadiposetissue
_version_ 1718432148689518592